Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jan 6:9:813625.
doi: 10.3389/fpubh.2021.813625. eCollection 2021.

The Construction and Development of a Clinical Prediction Model to Assess Lymph Node Metastases in Osteosarcoma

Wenle Li  1   2 , Shengtao Dong  3 , Bing Wang  2 , Haosheng Wang  4 , Chan Xu  2 , Kai Zhang  1   2 , Wanying Li  2 , Zhaohui Hu  5 , Xiaoping Li  6 , Qiang Liu  1 , Rilige Wu  7 , Chengliang Yin  8
Affiliations
Multicenter Study

The Construction and Development of a Clinical Prediction Model to Assess Lymph Node Metastases in Osteosarcoma

Wenle Li et al. Front Public Health. .

Abstract

Background: This study aimed to construct a clinical prediction model for osteosarcoma patients to evaluate the influence factors for the occurrence of lymph node metastasis (LNM). Methods: In our retrospective study, a total of 1,256 patients diagnosed with chondrosarcoma were enrolled from the SEER (Surveillance, Epidemiology, and End Results) database (training cohort, n = 1,144) and multicenter dataset (validation cohort, n = 112). Both the univariate and multivariable logistic regression analysis were performed to identify the potential risk factors of LNM in osteosarcoma patients. According to the results of multivariable logistic regression analysis, A nomogram were established and the predictive ability was assessed by calibration plots, receiver operating characteristics (ROCs) curve, and decision curve analysis (DCA). Moreover, Kaplan-Meier plot of overall survival (OS) was plot and a web calculator visualized the nomogram. Results: Five independent risk factors [chemotherapy, surgery, lung metastases, lymphatic metastases (M-stage) and tumor size (T-stage)] were identified by multivariable logistic regression analysis. What's more, calibration plots displayed great power both in training and validation group. DCA presented great clinical utility. ROCs curve provided the predictive ability in the training cohort (AUC = 0.805) and the validation cohort (AUC = 0.808). Moreover, patients in LNN group had significantly better survival than that in LNP group both in training and validation group. Conclusion: In this study, we constructed and developed a nomogram with risk factors, which performed well in predicting risk factors of LNM in osteosarcoma patients. It may give a guide for surgeons and oncologists to optimize individual treatment and make a better clinical decision.

Keywords: SEER; lymph node metastases; multicenter; nomogram; osteosarcoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Nomogram for osteosarcoma patients. (B,C) are training cohorts and the validation cohorts calibration diagram respectively, which indicate good consistency.
Figure 2
Figure 2
ROC curves for the training and validation group. (A) training group; (B) validation group.
Figure 3
Figure 3
(A,B) The Kaplan-Meier survival analysis patients with osteosarcoma in training and validation group. (C,D) Nomogram decision curve (DCA) of the training and validation group.
See this image and copyright information in PMC

References

    1. Marina N, Smeland S, Bielack S, Bernstein M, Jovic G, Hook J, et al. . “MAPIE vs MAP as postoperative chemotherapy in patients with a poor response to preoperative chemotherapy for newly-diagnosed osteosarcoma: results from EURAMOS-1 (Paper 032),” in Presented at Connective Tissue Oncology Society (2014).
    1. Tian Z, Niu X, Yao W. Receptor tyrosine kinases in osteosarcoma treatment: which is the key target? Front Oncol. (2020) 10:1642. 10.3389/fonc.2020.01642 - DOI - PMC - PubMed
    1. Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, et al. . Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. (2003) 21:2011–8. 10.1200/JCO.2003.08.132 - DOI - PubMed
    1. Hattori H, Yamamoto K. Lymph node metastasis of osteosarcoma. J Clin Oncol. (2012) 30:345–9. 10.1200/JCO.2012.42.3384 - DOI - PubMed
    1. Kempf-Bielack B. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. (2005) 23:559–68. 10.1200/JCO.2005.04.063 - DOI - PubMed

Publication types